|
HU168776B
(enExample)
|
1973-11-09 |
1976-07-28 |
|
|
|
HU168036B
(enExample)
|
1973-11-09 |
1976-02-28 |
|
|
|
US3962448A
(en)
*
|
1974-03-11 |
1976-06-08 |
Smithkline Corporation |
8-Alkyl and alkenyl-10-hydroxy-5H[1]benzopyranopyridine derivatives having polyphagic activity
|
|
CA1098910A
(en)
|
1978-06-15 |
1981-04-07 |
Robert N. Schut |
3-amino-2-(5-fluoro and 5-methoxy-1h-indol-3-yl) propanoic acid derivatives
|
|
JPS57116067A
(en)
|
1981-01-12 |
1982-07-19 |
Sankyo Kagaku Kk |
Novel 8-quinolinesulfonyl derivative, its synthesis and use
|
|
DE3703435A1
(de)
|
1987-02-05 |
1988-08-18 |
Thomae Gmbh Dr K |
Neue thiazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
IE68593B1
(en)
|
1989-12-06 |
1996-06-26 |
Sanofi Sa |
Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
|
|
US5945380A
(en)
|
1995-05-26 |
1999-08-31 |
Bayer Aktiengesellschaft |
Pyridyl-thiazoles and their use to protect plants against infections by micro-organisms
|
|
ES2196396T3
(es)
|
1996-12-23 |
2003-12-16 |
Bristol Myers Squibb Pharma Co |
Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa.
|
|
US6187797B1
(en)
|
1996-12-23 |
2001-02-13 |
Dupont Pharmaceuticals Company |
Phenyl-isoxazoles as factor XA Inhibitors
|
|
ATE257703T1
(de)
|
1997-10-27 |
2004-01-15 |
Takeda Chemical Industries Ltd |
1,3-thiazole als adenosine a3 rezeptor antagonisten zur behandlung von asthma, allergien und diabetes
|
|
WO1999052906A1
(de)
|
1998-04-08 |
1999-10-21 |
Bayer Aktiengesellschaft |
Substituierte oxazolyl- und thiazolyl-uracil herbizide
|
|
CA2380206A1
(en)
|
1999-07-26 |
2001-02-01 |
Shionogi & Co., Ltd. |
Pharmaceutical compositions exhibiting thrombopoietin receptor agonism
|
|
WO2001068648A1
(en)
*
|
2000-03-15 |
2001-09-20 |
Aventis Pharma Deutschland Gmbh |
Substituted beta-carbolines with ikb-kinase inhibiting activity
|
|
MEP28108A
(en)
*
|
2000-03-15 |
2010-10-10 |
Sanofi Aventis Deutschland |
Substituted beta-carbolines with ikb-kinase inhibiting activity
|
|
GB0010183D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
|
EP1310494B1
(en)
|
2000-08-11 |
2012-01-25 |
Nippon Chemiphar Co., Ltd. |
PPAR (delta) ACTIVATORS
|
|
JP2002053566A
(ja)
|
2000-08-11 |
2002-02-19 |
Japan Tobacco Inc |
チアゾール化合物及びその医薬用途
|
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
|
US20020103192A1
(en)
|
2000-10-26 |
2002-08-01 |
Curtin Michael L. |
Inhibitors of histone deacetylase
|
|
EP1354603A1
(en)
|
2000-12-26 |
2003-10-22 |
Takeda Chemical Industries, Ltd. |
Concomitant drugs
|
|
US20040077697A1
(en)
|
2001-02-02 |
2004-04-22 |
Hiroyuki Koshio |
2-Acylaminothiazole derivative or its salt
|
|
MY130778A
(en)
|
2001-02-09 |
2007-07-31 |
Vertex Pharma |
Heterocyclic inhibitiors of erk2 and uses thereof
|
|
US20020177594A1
(en)
|
2001-03-14 |
2002-11-28 |
Curtin Michael L. |
Inhibitors of histone deacetylase
|
|
EP1371650A4
(en)
|
2001-03-23 |
2005-05-04 |
Nippon Chemiphar Co |
ACTIVATED RECEPTOR ACTIVATOR BY PEROXYSOME PROLIFIERS
|
|
CA2665516A1
(en)
|
2001-04-26 |
2002-11-07 |
Daiichi Pharmaceutical Co., Ltd. |
Drug efflux pump inhibitor
|
|
EP1402900A1
(en)
|
2001-06-11 |
2004-03-31 |
Takeda Chemical Industries, Ltd. |
Medicinal compositions
|
|
GB0123589D0
(en)
|
2001-10-01 |
2001-11-21 |
Syngenta Participations Ag |
Organic compounds
|
|
US7163952B2
(en)
|
2001-12-03 |
2007-01-16 |
Japan Tobacco Inc. |
Azole compound and medicinal use thereof
|
|
US7638536B2
(en)
|
2002-01-18 |
2009-12-29 |
Astellas Pharma Inc. |
2-Acylaminothiazole derivative or salt thereof
|
|
CA2474322A1
(en)
|
2002-01-25 |
2003-07-31 |
Kylix Pharmaceuticals B.V. |
4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
|
|
JP2005529923A
(ja)
|
2002-05-13 |
2005-10-06 |
イーライ・リリー・アンド・カンパニー |
肥満および糖尿病の治療におけるメラニン凝集ホルモンアンタゴニストとして使用するための多環式化合物
|
|
WO2004009017A2
(en)
|
2002-07-18 |
2004-01-29 |
Bristol-Myers Squibb Company |
Modulators of the glucocorticoid receptor and method
|
|
TW200424183A
(en)
|
2002-08-09 |
2004-11-16 |
Nps Pharma Inc |
New compounds
|
|
AU2003265395A1
(en)
|
2002-08-14 |
2004-03-03 |
Ppd Discovery, Inc. |
Prenylation inhibitors and methods of their synthesis and use
|
|
JP2006514684A
(ja)
|
2002-10-30 |
2006-05-11 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｒｏｃｋおよび他のプロテインキナーゼとして有用な組成物
|
|
GB0230087D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
|
GB0302672D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
|
WO2004071509A1
(ja)
|
2003-02-12 |
2004-08-26 |
Nippon Chemiphar Co., Ltd. |
オリゴデンドロサイト分化促進剤
|
|
PL1611088T3
(pl)
|
2003-04-07 |
2009-11-30 |
Pharmacyclics Inc |
Hydroksamiany jako środki terapeutyczne
|
|
JP2006523710A
(ja)
|
2003-04-16 |
2006-10-19 |
メモリー・ファーマシューティカルズ・コーポレイション |
ホスホジエステラーゼ４インヒビター
|
|
CN100545161C
(zh)
|
2003-08-15 |
2009-09-30 |
中国科学院上海药物研究所 |
一类杂环衍生物、制备方法及其用途
|
|
US7351727B2
(en)
|
2003-09-02 |
2008-04-01 |
Bristol-Myers Squibb Company |
Inhibitors of 15-lipoxygenase
|
|
MXPA06002567A
(es)
|
2003-09-06 |
2006-09-04 |
Vertex Pharma |
Moduladores de transportadores con casete de union de atp.
|
|
SA04250288B1
(ar)
|
2003-09-19 |
2008-07-19 |
سولفاي فارماسوتيكالز بي . في |
مشتقات ثيازول thiazole كمعدلات لمستقبل المكونات الكيميائية للقنب cannabinoid
|
|
WO2005044194A2
(en)
|
2003-10-28 |
2005-05-19 |
Pharmacia Corporation |
TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR
|
|
MXPA06004657A
(es)
|
2003-10-28 |
2006-06-27 |
Pharmacia Corp |
Combinaciones que comprenden un inhibidor de hsp90 y un inhibidor de fosfodiesterasa para tratar o prevenir la neoplasia.
|
|
EP1713775A4
(en)
|
2004-01-30 |
2009-08-12 |
Smithkline Beecham Corp |
CHEMICAL COMPOUNDS
|
|
WO2005075435A1
(en)
|
2004-01-30 |
2005-08-18 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
|
MY148488A
(en)
|
2004-02-18 |
2013-04-30 |
Astrazeneca Ab |
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2005077900A1
(ja)
|
2004-02-18 |
2005-08-25 |
Kyorin Pharmaceutical Co., Ltd. |
ビシクロアミド誘導体
|
|
US7259155B2
(en)
|
2004-05-05 |
2007-08-21 |
Otsuka Pharmaceutical Factory, Inc. |
Phosphonic diester derivatives
|
|
TW200637559A
(en)
|
2005-03-29 |
2006-11-01 |
Shionogi & Co |
3-propenylcefem derivative
|
|
FR2885129B1
(fr)
|
2005-04-29 |
2007-06-15 |
Proskelia Sas |
Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation.
|
|
SG159561A1
(en)
|
2005-05-09 |
2010-03-30 |
Achillion Pharmaceuticals Inc |
Thiazole compounds and methods of use
|
|
US7655446B2
(en)
|
2005-06-28 |
2010-02-02 |
Vertex Pharmaceuticals Incorporated |
Crystal structure of Rho-kinase I kinase domain complexes and binding pockets thereof
|
|
BRPI0615524A2
(pt)
*
|
2005-07-11 |
2010-04-06 |
Devgen Nv |
derivados da amida como inibidores da quinase
|
|
WO2007062222A2
(en)
|
2005-11-22 |
2007-05-31 |
University Of South Florida |
Inhibition of cell proliferation
|
|
WO2007075896A2
(en)
|
2005-12-22 |
2007-07-05 |
Kemia, Inc. |
Heterocyclic cytokine inhibitors
|
|
TWI444370B
(zh)
|
2006-01-25 |
2014-07-11 |
Synta Pharmaceuticals Corp |
用於發炎及免疫相關用途之噻唑及噻二唑化合物
|
|
WO2007116106A1
(es)
|
2006-04-12 |
2007-10-18 |
Palobiofarma, S.L. |
Nuevos compuestos como antagonistas de los receptores a1 de adenosina
|
|
RU2008148962A
(ru)
|
2006-05-12 |
2010-06-20 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Избирательно действующие ингибиторы rоск протеинкиназы и их применение
|
|
JP5448164B2
(ja)
|
2006-07-28 |
2014-03-19 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｂ２受容体を変調する化合物
|
|
JP5030114B2
(ja)
|
2006-09-25 |
2012-09-19 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｂ２受容体をモジュレートする化合物
|
|
TW200831081A
(en)
|
2006-12-25 |
2008-08-01 |
Kyorin Seiyaku Kk |
Glucokinase activator
|
|
WO2008124000A2
(en)
|
2007-04-02 |
2008-10-16 |
Ligand Pharmaceuticals Incorporated |
Thiazole derivatives as androgen receptor modulator compounds
|
|
GB0706793D0
(en)
|
2007-04-05 |
2007-05-16 |
Evotec Ag |
Compounds
|
|
CN101801362B
(zh)
|
2007-06-22 |
2014-01-22 |
海德拉生物科学公司 |
用于治疗病症的方法和组合物
|
|
CA2697382A1
(en)
|
2007-08-27 |
2009-03-05 |
Abbott Gmbh & Co. Kg |
4-(4-pyridinyl)-benzamides and their use as rock activity modulators
|
|
WO2009026701A1
(en)
|
2007-08-29 |
2009-03-05 |
Methylgene Inc. |
Sirtuin inhibitors
|
|
ES2331220B1
(es)
|
2007-10-02 |
2010-09-23 |
Palobiofarma, S.L. |
Nuevos compuestos como antagonistas de los receptores a1 de adenosina.
|
|
CA2699631A1
(en)
|
2007-10-31 |
2009-05-07 |
Nissan Chemical Industries, Ltd. |
Pyridazinone compounds and p2x7 receptor inhibitors
|
|
JP5492092B2
(ja)
|
2007-11-07 |
2014-05-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｂ２受容体を調節する化合物
|
|
WO2009067607A2
(en)
|
2007-11-20 |
2009-05-28 |
Memory Pharmaceuticals Corporation |
Combinations of pde4 inhibitors and antipsychotics for the treatment of psychotic disorders
|
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
WO2009081222A1
(en)
|
2007-12-21 |
2009-07-02 |
Glenmark Pharmaceuticals, S.A. |
Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands
|
|
EP2251001A4
(en)
|
2008-02-08 |
2013-01-09 |
Shiseido Co Ltd |
SKIN BLEACHING AND EXTERNAL PREPARATION FOR THE SKIN
|
|
WO2009114552A1
(en)
|
2008-03-10 |
2009-09-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Heteroaryl compounds, compositions, and methods of use in cancer treatment
|
|
WO2009140519A1
(en)
|
2008-05-14 |
2009-11-19 |
Hydra Biosciences, Inc. |
Compounds and compositions for treating chemical warfare agent-induced injuries
|
|
WO2010028193A1
(en)
|
2008-09-03 |
2010-03-11 |
Repligen Corporation |
Compounds including pimelic acid derivatives as hdac inhibitors
|
|
US20100063085A1
(en)
*
|
2008-09-11 |
2010-03-11 |
University Court Of The University Of Dundee |
Method of treating learning impairment in down's syndrome subjects
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
WO2010036821A1
(en)
|
2008-09-24 |
2010-04-01 |
Hydra Biosciences, Inc. |
Methods and compositions for treating respiratory disorders
|
|
CN102325752B
(zh)
*
|
2008-12-19 |
2015-02-04 |
百时美施贵宝公司 |
咔唑和咔啉激酶抑制剂
|
|
PL2379537T3
(pl)
|
2008-12-19 |
2013-03-29 |
Elanco Tiergesundheit Ag |
Pochodne izooksazoliny i ich zastosowanie jako pestycydów
|
|
WO2010075376A2
(en)
|
2008-12-23 |
2010-07-01 |
Abbott Laboratories |
Anti-viral compounds
|
|
JP2012051804A
(ja)
*
|
2008-12-26 |
2012-03-15 |
Kyoto Univ |
Ｅｇ５阻害剤
|
|
UA103918C2
(en)
|
2009-03-02 |
2013-12-10 |
Айерем Элелси |
N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
|
|
US8362249B2
(en)
|
2009-04-27 |
2013-01-29 |
Boehringer Ingelheim International Gmbh |
CXCR3 receptor antagonists
|
|
AU2010258974A1
(en)
|
2009-06-09 |
2012-01-12 |
California Capital Equity, Llc |
Pyridil-triazine inhibitors of hedgehog signaling
|
|
JP2013503174A
(ja)
|
2009-08-25 |
2013-01-31 |
アブラクシス バイオサイエンス， エルエルシー |
タキサンおよびヘッジホッグ阻害剤のナノ粒子組成物を使用する併用療法
|
|
JP5856064B2
(ja)
|
2009-11-17 |
2016-02-09 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
治療特性を有する１，４−ベンゾジアゼピン−２，５−ジオンおよび関連化合物
|
|
CA2783801A1
(en)
|
2009-12-18 |
2011-06-23 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
JP5766690B2
(ja)
|
2010-04-12 |
2015-08-19 |
塩野義製薬株式会社 |
インテグラーゼ阻害活性を有するピリドン誘導体
|
|
WO2011130740A2
(en)
|
2010-04-16 |
2011-10-20 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use
|
|
US8685969B2
(en)
*
|
2010-06-16 |
2014-04-01 |
Bristol-Myers Squibb Company |
Carboline carboxamide compounds useful as kinase inhibitors
|
|
US9000154B2
(en)
|
2010-10-19 |
2015-04-07 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
|
US8703953B2
(en)
|
2012-03-09 |
2014-04-22 |
Bristol-Myers Squibb Company |
Aryl ether-base kinase inhibitors
|
|
ES2634628T3
(es)
|
2013-07-02 |
2017-09-28 |
Bristol-Myers Squibb Company |
Derivados tricíclicos de pirido-carboxamida como inhibidores ROCK
|
|
EP3016951B1
(en)
|
2013-07-02 |
2017-05-31 |
Bristol-Myers Squibb Company |
Tricyclic pyrido-carboxamide derivatives as rock inhibitors
|